Announcements Trials
Browse Landscape

Phase

Phase 2 45Phase 3 13Phase 1/2 13Phase NA 11Phase 1 11Phase 4 3Phase EARLY_PHASE1 2Phase 2/3 2

Status

Terminated 1Recruiting 1Completed 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Classical hematology 3Other hematologic neoplasm 1Myeloid 1Gynecologic 1

Conditions

Anemia 30Neoplasms 21Febrile Neutropenia 19Venous Thromboembolism 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Neutropenia 5Leukemia, Myeloid, Acute 5Colorectal Neoplasms 5Pulmonary Embolism 4Myelodysplastic Syndromes 4Leukemia 4Fever 4Anemia, Iron-Deficiency 4Venous Thrombosis 3Thrombocytopenia 3Ovarian Neoplasms 3Multiple Myeloma 3Lymphoma, Non-Hodgkin 3Hematologic Neoplasms 3Breast Neoplasms 3Adenocarcinoma 3Vitamin D Deficiency 2Uterine Cervical Neoplasms 2Stomach Neoplasms 2Sepsis 2Recurrence 2Postoperative Complications 2Lymphoma, Follicular 2Lymphoma 2Infections 2

Interventions

eltrombopag 1Tinzaparin 1Pharmacokinetics 1Enoxaparin 1Dalteparin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × Thrombocytopenia × Classical hematology × Clear all
NCT05255003 2025-12-17

STrategies for Anticoagulation in Patients With thRombocytopenia and Cancer-associated Thrombosis

Ottawa Hospital Research Institute

Phase 4 Recruiting
50 enrolled
Classical hematology

Thrombocytopenia

NCT04861181 2025-05-22

NIRAPK

Hospices Civils de Lyon

Phase 4 Terminated
12 enrolled
Classical hematologyGynecologic

Ovarian Neoplasms, Recurrence, Thrombocytopenia

NCT01957176 2022-12-30

A Rollover Study to Provide Continued Treatment With Eltrombopag

Novartis

Phase 4 Completed
22 enrolled 9 charts
Classical hematologyMyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Thrombocytopenia, Leukemia, Myeloid, Acute, Purpura, Thrombocytopenic, Idiopathic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡